UNIVERSITE DE KINSHASA
- Country
- Congo, The Democratic Republic of the
- Type
- Beneficiary
- Grants received
- 11
Funding record
- 11 grants on record
- €8,016,525.73 awarded in total
- 2008–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
1 further grant is on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE
- NATIONAL INSTITUTE FOR MEDICAL RESEARCH
- STICHTING AMSTERDAM UMC
- UNIVERSITEIT ANTWERPEN
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- FONDATION CONGOLAISE POUR LA RECHERCHE MEDICALE
- FONDAZIONE PENTA ETS
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Calls from this organisation
No published calls from this organisation.
Grants received
- Central Africa Training Platform for Clinical Research on infectious diseases
- Strengthening epidemiological, genomic and community surveillance of Mpox virus (MPXV) at the Congo River border for DRC and RoC
- Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa
- MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF A TWO-DOSE MPOX VACCINE
- SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL
- Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women - Extended
- Strengthening Environmental Surveillance to Advance Public Health Action
- SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings]
- SARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts
- Bringing a prophylactic Ebola vaccine to licensure
- Migration between Africa and Europe
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.